FDAFDA · Food and drugs·Recall number D-0873-2022
Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Published May 25, 2022 · Recall initiated: April 22, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.